In severe and fatal asthma dramatic changes in airway structure have been described, collectively referred to as remodelling 1, 2. Current dogma dictates that remodelling reflects aberrant repair in response to ongoing inflammation and injury. However, the interplay between inflammation and remodelling, and, more importantly, between airway structure and function remains elusive, such that we remain uncertain whether these changes protect the airways from the effects of inflammation or are integral to disease progression. To begin to unravel this conundrum we need to recognise the complexity and heterogeneity of asthma. The asthma paradigm comprises several domains, including ongoing symptoms, the presence of variable airflow obstruction and airway hyperresponsiveness. Together with such disordered airway physiology, most subjects with asthma have evidence of a chronic inflammatory response that is typically, but not exclusively, eosinophilic, with the presence of mast cells within the airway smooth muscle bundle 3–5. In addition, there is often evidence of structural remodelling of the airway wall with thickening of the reticular lamina, mucus gland hyperplasia, increased vasculature, and increased airway smooth muscle hyperplasia and hypertrophy. Importantly, some features of remodelling, particularly thickening of the lamina reticularis, can occur early on in disease and even in some children prior to the onset of asthma 6. In contrast, other aspects of the remodelling process have been associated with disease duration 7. In addition to structural and inflammatory cells, the airway wall is comprised of extracellular matrix, the composition of which varies between different compartments in the airway wall, between asthma versus health, and across disease severity. This matrix is not a benign bystander that simply constitutes the scaffold to build airway structures and allow inflammatory cell trafficking, but can alter …
Read full abstract